-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Avalo Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2015 to 2024.
- Avalo Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2025 was $16K, a 129% increase year-over-year.
- Avalo Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2025 was $124K, a 854% increase year-over-year.
- Avalo Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2024 was $114K, a 714% increase from 2023.
- Avalo Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $14K, a 50% decline from 2022.
- Avalo Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $28K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)